This information can then be used to create context-specific network models in a way that does not depend on prior knowledge of KSRs or other information, and which can identify possible tumor vulnerabilities, for example, TTK in acute myeloid leukemia (AML) (Hijazi et al., 2020). This evidence concerns the gene TTK and acute myeloid leukemia.